Company Description
"The few, the proud, the profitable" could be Genentech's motto. One of the world's most successful biotechs (in an industry full of...
Key Genentech Financials
| Company Type | Public - NYSE: DNA Main Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2007 Sales (mil.) | $11,724.0 |
| 2007 Employees | 11,174 |
More Genentech Financials (11 pages)
Latest Genentech Jobs jobs by Indeed
Rankings
- #75 in FT Global 500
Competition
Competitive Landscape for Biotechnology Sector
Demand for biotechnology products and services is driven primarily by the willingness of insurers to pay for new medical treatments. The profitability of individual companies depends on the...
Read more about Genentech's competition across multiple industries
Top Genentech Competitors
Sponsored Links
The Business DirectoryTrading Toolbox
Genentech Executives sponsored by genius.com
| Title | Name & Bio | Contact |
|---|---|---|
| Chairman, President, and CEO | Arthur D. (Art) Levinson | Network | E-mail |
| EVP and CFO | David A. Ebersman | Network | E-mail |
| SVP Development and Chief Medical Officer | Hal V. Barron | Network | E-mail |
| Are You Listed On Hoover's? | ||
|---|---|---|
| Hoover's subscribers also get access to information on people who have self-listed with this company. Subscribers also have the option to add themselves to this company record. |
Tools from our advertising partners:
Current Genentech News
- Exact Sciences Changes Corporate Strategy [InvesTrend] (17 Jul 2008 00:01:00 EDT)
- Biogen Idec Shares Surge As Rituxan Partner Genentech Posts 2Q Sales Surge [InvesTrend] (16 Jul 2008 00:01:00 EDT)
- Cytori Therapeutics Given Patent On Stem Cell Methodology [InvesTrend] (16 Jul 2008 00:01:00 EDT)
Latest Genentech Video
-
Genentech (DNA) Product Development President Dr. Susan Desmond-Hellman (5:02)
06/04/07 9:45ET - CNBC's Mike Huckman interviews Dr. Desmond-Hellman about positive phase 3 trials of lung cancer drug Avastin.